Intraarterial route increases the risk of cerebral lesions after mesenchymal cell administration in animal model of ischemia

Mesenchymal stem cells (MSCs) are a promising clinical therapy for ischemic stroke. However, critical parameters, such as the most effective administration route, remain unclear. Intravenous (i.v.) and intraarterial (i.a.) delivery routes have yielded varied outcomes across studies, potentially due...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Argibay, Bárbara, Trekker, Jesse, Himmelreich, Uwe, Beiras, Andrés, Topete, Antonio, Taboada, Pablo, Pérez-Mato, María, Vieites-Prado, Alba, Iglesias-Rey, Ramón, Rivas, José, Planas, Anna M., Sobrino, Tomás, Castillo, José, Campos, Francisco
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5238501/
https://ncbi.nlm.nih.gov/pubmed/28091591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep40758
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars